SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer

SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer CAMBRIDGE, Mass. – June 25, 2019 – SmartPharm Therapeutics, a pre-clinical stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, has been appointed Chief Executive Officer. Dr. [...]